How much is the market price of brigatinib?

Brigatinib (Brigatinib) is a targeted drug used to treat non-small cell lung cancer (NSCLC), specifically in patients with anaplastic lymphoma kinase (ALK)-positive mutations. Brigatinib (Brigatinib) ByARIC Developed by Pharmaceuticals, it was approved by the U.S. Food and Drug Administration (FDA) in 2017 and has become one of the important drugs for the treatment of ALKpositive NSCLC.

Brigatinib is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically for about four to five thousand yuan. For specific prices and medical insurance reimbursement, please consult the local hospital pharmacy. The cheaper generic drugs abroad are generic drugs. The cheaper generic drugs in Laos cost about a few hundred yuan, which are much cheaper than domestic ones, and the ingredients of the drugs are basically the same.

Clinical trials have shown that brigatinib (Brigatinib) has a higher response rate and longer progression-free survival in the treatment of ALKpositive NSCLC patients. Particularly for patients who have failed treatment with other ALK inhibitors such as crizotinib, brigatinib offers an effective alternative. Its multi-target inhibitory properties enable it to exhibit good therapeutic effects in a variety of situations.

Although brigatinib is effective, it may also cause a series of adverse reactions. Common adverse reactions include interstitial lung disease (ILD), hypertension, visual impairment, bradycardia and gastrointestinal reactions. Patients should closely monitor these adverse reactions during treatment and promptly report any abnormalities to their doctors for appropriate treatment and adjustments.

Brigatinib as a targeted therapy in oral tablet form, provides a convenient and effective treatment option for ALKpositiveNSCLC patients. by inhibitingALKThe activity of ALK and other related enzymes blocks the growth signals of cancer cells, thereby effectively controlling cancer progression. Despite potential adverse effects, with regular monitoring and guidance from medical staff, brigatinib (brigatinib) can play an important role in prolonging patient survival and improving quality of life.